[分享]Good Manufacturing Practices for Pharmaceuticals

太好了,多谢了

上面的下载连接失效了！
现在最新版是第六版



Good Manufacturing Practices for Pharmaceuticals, Sixth Edition A Plan for Total Quality Control from Manufacturer to Consumer, Sixth Edition
Editors: Joseph D. Nally
ISBN: 978-0-8493-3972-1 (hardback) 978-1-4200-2093-9 (electronic)
Series: Drugs and the Pharmaceutical Sciences
Subjects: Analysis & Pharmaceutical Quality; Pharmaceutical Manufacturing; Pharmaceutical Science Regulatory;
Publisher: Informa Healthcare, USA
Purchase eBook: US$169.95 - buy now add to cart
Sign In Purchase Printed Book
This book is not available as an ebook on Informaworld. If you would like to receive information about this title, please email us at books@informausa.com
Summary
With global harmonization of regulatory requirements and quality standards and national and global business consolidations ongoing at a fast pace, pharmaceutical manufacturers, suppliers, contractors, and distributors are impacted by continual change. Offering a wide assortment of policy and guidance document references and interpretations, this Sixth Edition is significantly expanded to reflect the increase of information and changing practices in CGMP regulation and pharmaceutical manufacturing and control practices worldwide. An essential companion for every pharmaceutical professional, this guide is updated and expanded by a team of industry experts, each member with extensive experience in industry or academic settings.
Table of Contents
Status and Applicability of U.S. Regulations. Finished Pharmaceuticals General Provisions (Subpart A). Organization and Personnel (Subpart B). Buildings and Facilities (Subpart C). Equipment (Subpart D). Control of Components and Drug Product Containers and Closures (Subpart E). Production and Process Controls (Subpart F). Packaging and Labeling Control (Subpart G). Holding and Distribution (Subpart H). Laboratory Controls (Subpart I). Records and Reports (Subpart J). Returned and Salvaged Drug Products (Subpart K). Repacking and Relabeling. Quality Systems and Risk Management Approaches. Clinical Trial Supplies and GMPs. Contracting and Outsourcing. Active Pharmaceutical Ingredients. Bulk Pharmaceutical Excipient GMPs. Recalls, Warning Letter, Seizures and Injunctions: CGMP Enforcement Alternatives in the United States. Controlled Substances Safeguards. The Inspection Procedure for Compliance in the United States: The Regulatee Is Inspected; The Rationale for Inspection. FDA Pre-Approval Inspections/Investigations: The Road from SUPAC to the Food and Drug Modernization Act. Worldwide GMPs. Quality Approaches: ISO 9000, Malcolm Baldrige and Six Sigma. Appendix A: Center for Drug Evaluation and Research (CDER) List of Guidance Documents. Appendix B: ICH Guidelines. Appendix C: FDA / ORA Compliance Policy Guides

thanks for sharing!